Skip to main content
Top
Published in: Medical Oncology 1/2011

01-12-2011 | Original Paper

T(1;21;8)(p34;q22;q22): a novel variant of t(8;21) in acute myeloblastic leukemia with maturation

Authors: Abir Gmidène, Rim Frikha, Hlima Sennana, Hatem Elghezal, Moez Elloumi, Ali Saad

Published in: Medical Oncology | Special Issue 1/2011

Login to get access

Abstract

The complex variants of t(8;21) involving chromosomes 8 and 21 as well as another chromosome account for approximately 3% of acute myeloid leukemia patients. We report here a 30-year-old male patient with AML-M2. Fluorescence in situ hybridization analysis using dual-color fluorescence ETO and AML1 probes located at 8q22 and 21q22 respectively showed an AML1/ETO fusion signal on the derivative chromosome 8. Whole chromosome painting probes were used for chromosome 1, 8 and 21 and revealed a three-way translocation (1;21;8)(p34 ~ p35;q22;q22). Involvement of chromosome region 1p34 has never been reported earlier, although region 1p35 as a variant in AML with t(8;21) has been reported with an AML1/ETO fusion signal on the 1p35 rather than der(8). In conclusion, combining conventional karyotype, FISH or RT–PCR analyses are a rational strategy for the identification of the complex variants of t(8;21) translocation which could be critical events responsible for leukemogenesis.
Literature
1.
go back to reference Xiao Z, et al. Molecular characterization of genomic AML1-ETO fusions in childhood leukemia. Leukemia. 2001;15:1906–13.PubMedCrossRef Xiao Z, et al. Molecular characterization of genomic AML1-ETO fusions in childhood leukemia. Leukemia. 2001;15:1906–13.PubMedCrossRef
2.
go back to reference Farra C, Awwad J, Valent A, Lozach F, Bernheim A. Complex translocation (8;12;21): a new variant of t(8;21) in acute myeloid leukemia. Cancer Genet Cytogenet. 2004;155:138–42.PubMedCrossRef Farra C, Awwad J, Valent A, Lozach F, Bernheim A. Complex translocation (8;12;21): a new variant of t(8;21) in acute myeloid leukemia. Cancer Genet Cytogenet. 2004;155:138–42.PubMedCrossRef
3.
4.
go back to reference Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;1(100):2292–302.CrossRef Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;1(100):2292–302.CrossRef
5.
go back to reference Udayakumar AM, Alkindi S, Pathare AV, Raeburn JA. Complex t(8;13;21)(q22;q14;q22) :a novel variant of t(8;21) in a patient with acute myeloid leukemia (AML-M2). Arch Med Res. 2008;39:252–6.PubMedCrossRef Udayakumar AM, Alkindi S, Pathare AV, Raeburn JA. Complex t(8;13;21)(q22;q14;q22) :a novel variant of t(8;21) in a patient with acute myeloid leukemia (AML-M2). Arch Med Res. 2008;39:252–6.PubMedCrossRef
6.
go back to reference Kawakami K, et al. A case of acute myeloblastic leukemia with a novel variant of t(8;21)(q22;q22). Int J Hematol. 2008;87:78–82.PubMedCrossRef Kawakami K, et al. A case of acute myeloblastic leukemia with a novel variant of t(8;21)(q22;q22). Int J Hematol. 2008;87:78–82.PubMedCrossRef
7.
go back to reference Sennana SH, et al. Cytogenetic analysis in 139 Tunisian patients with de novo acute myeloid leukemia. Ann Genet. 2002;45:29–32.CrossRef Sennana SH, et al. Cytogenetic analysis in 139 Tunisian patients with de novo acute myeloid leukemia. Ann Genet. 2002;45:29–32.CrossRef
8.
go back to reference Mitelman F, editor. An International System for Human Cytogenetic Nomenclature (ISCN): Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger; 2009. Mitelman F, editor. An International System for Human Cytogenetic Nomenclature (ISCN): Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger; 2009.
9.
go back to reference Gmidène A, et al. ETV6-RUNX1 rearrangement in Tunisian pediatric B-lineage acute lymphoblastic leukemia. Adv Hematol. 2009;2009:1–5.CrossRef Gmidène A, et al. ETV6-RUNX1 rearrangement in Tunisian pediatric B-lineage acute lymphoblastic leukemia. Adv Hematol. 2009;2009:1–5.CrossRef
10.
go back to reference Huang LI, Abruzzo LV, Valbuena JR, Medeiros LJ, Lin P. Acute myeloid leukemia associated with variant t(8;21) detected by conventional cytogenetic and molecular studies: a report of four cases and review of the literature. Am J Clin Pathol. 2006;125:267–72.PubMed Huang LI, Abruzzo LV, Valbuena JR, Medeiros LJ, Lin P. Acute myeloid leukemia associated with variant t(8;21) detected by conventional cytogenetic and molecular studies: a report of four cases and review of the literature. Am J Clin Pathol. 2006;125:267–72.PubMed
11.
go back to reference Kondo K, Sasaki M, Mikuni C. A complex translocation involving chromosomes 1, 8 and 21 in acute myeloblastic leukemia. Proc Jpn Acad. 1978;54:21–4.CrossRef Kondo K, Sasaki M, Mikuni C. A complex translocation involving chromosomes 1, 8 and 21 in acute myeloblastic leukemia. Proc Jpn Acad. 1978;54:21–4.CrossRef
12.
go back to reference Oguma N, Misawa S, Testa JR. A variant 8;21 translocation in acute myeloblastic leukemia. Am J Hematol. 1983;15:391–6.PubMedCrossRef Oguma N, Misawa S, Testa JR. A variant 8;21 translocation in acute myeloblastic leukemia. Am J Hematol. 1983;15:391–6.PubMedCrossRef
13.
go back to reference Testa JR, Misawa S, Oguma N, Van Sloten K, Wiernik PH. Chromosomal alterations in acute leukemia patients studied with improved culture methods. Cancer Res. 1985;45:430–4.PubMed Testa JR, Misawa S, Oguma N, Van Sloten K, Wiernik PH. Chromosomal alterations in acute leukemia patients studied with improved culture methods. Cancer Res. 1985;45:430–4.PubMed
14.
go back to reference Rubnitz JE, et al. Characteristics and outcome of t(8;21)-positive childhood acute myeloid leukemia: a single institution’s experience. Leukemia. 2002;16:2072–7.PubMedCrossRef Rubnitz JE, et al. Characteristics and outcome of t(8;21)-positive childhood acute myeloid leukemia: a single institution’s experience. Leukemia. 2002;16:2072–7.PubMedCrossRef
15.
go back to reference Tirado CA, et al. A cryptic t(1;21;8)(p36;q22;q22) in a case of acute myeloid leukemia with maturation. J Assoc Genet Technol. 2009;35:88–92. Tirado CA, et al. A cryptic t(1;21;8)(p36;q22;q22) in a case of acute myeloid leukemia with maturation. J Assoc Genet Technol. 2009;35:88–92.
16.
go back to reference Ahmad F, et al. Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2. Cancer Genet Cytogenet. 2008;180:153–7.PubMedCrossRef Ahmad F, et al. Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2. Cancer Genet Cytogenet. 2008;180:153–7.PubMedCrossRef
17.
go back to reference Nguyen TT, et al. Identification of novel Runx1 (AML1) translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute myeloid leukemia. Genes Chromosomes Cancer. 2006;45:918–32.PubMedCrossRef Nguyen TT, et al. Identification of novel Runx1 (AML1) translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute myeloid leukemia. Genes Chromosomes Cancer. 2006;45:918–32.PubMedCrossRef
18.
go back to reference Miyamoto T, Weissman IL, Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci USA. 2000;97:7521–6.PubMedCrossRef Miyamoto T, Weissman IL, Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci USA. 2000;97:7521–6.PubMedCrossRef
Metadata
Title
T(1;21;8)(p34;q22;q22): a novel variant of t(8;21) in acute myeloblastic leukemia with maturation
Authors
Abir Gmidène
Rim Frikha
Hlima Sennana
Hatem Elghezal
Moez Elloumi
Ali Saad
Publication date
01-12-2011
Publisher
Springer US
Published in
Medical Oncology / Issue Special Issue 1/2011
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9703-0

Other articles of this Special Issue 1/2011

Medical Oncology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.